VP of Regulatory Compliance and Sr. Director Regulatory Compliance and Director Quality Assurnace @ Therapeutic Proteins Inc. (April 2009 - March 2012)
Director of Quality Assurance and Regulatory Affairs @ (January 2007 - January 2009)
Director of Quality Assurance and Regulatory Affairs @ Stericon (January 2003 - January 2007)
Director of Quality Control @ Regis Technologies (January 1993 - January 2003)
Daniel Bernier Education
Illinois Institute of Technology
MS
2001
Northern Illinois University
Bachelor’s Degree
1993
Keller Graduate School of Management of DeVry University
Master of Business Administration - MBA
2024
Daniel Bernier Skills
Alliance Management
Analytical Chemistry
Auditing
Biopharmaceuticals
Biosimilars
Biotechnology
Business Strategy
CAPA
CMC Regulatory Affairs
CRO Management
Chemistry, Manufacturing, and Controls (CMC)
Clinical Development
Clinical Trials
Coaching
Communication
Compliance
Contract Negotiation
Corrective and Preventive Action (CAPA)
Cross-functional Team Leadership
Environment, Health, and Safety (EHS)
Environmental Compliance
FDA
GCP
GLP
GMP
Good Laboratory Practice (GLP)
Good Manufacturing Practice (GMP)
GxP
Leadership
Legal Research
Management
Manufacturing
Medical Devices
Pharmaceutical Industry
Pharmaceuticals
Project Management
Quality Assurance
Quality Auditing
Quality Control
Quality Systems
Regulatory Affairs
Regulatory Audits
Regulatory Requirements
Regulatory Submissions
Research and Development (R&D)
Standard Operating Procedure (SOP)
Start-ups
Technology Transfer
U.S. Food and Drug Administration (FDA)
Validation
Vendor Management
21 CFR
Good Laboratory Practice Glp
Verification And Validation V&V
HPLC
Regulatory
Change Control
Life Sciences
Corrective And Preventive Action Capa
Strategy
Operations
Quality System
Research And Development R&D
Risk Management
Pharmaceutics
Cross Functional Team Leadership
Marketing
U.S. Food And Drug Administration Fda
Biologics
Regulatory Compliance
Clinical Operations
Standard Operating Procedure Sop
Sop
21 CFR Part 11
u.s. Food and Drug Administration
Standard Operating Procedure
Corrective and Preventive Action
Good Laboratory Practice
Verification and Validation
Research and Development
Start Ups
Equipment Maintenance
Daniel Bernier Summary
Daniel Bernier, based in Chapel Hill, NC, US, is currently a Sr. Director - Global Regulatory Affairs - Pre-Approval at Eli Lilly and Company. Daniel Bernier brings experience from previous roles at Eli Lilly and Company, POINT Biopharma, Medicago and KBI Biopharma. Daniel Bernier holds a MS @ Illinois Institute of Technology. With a robust skill set that includes Alliance Management, Analytical Chemistry, Auditing, Biopharmaceuticals, Biosimilars and more. Daniel Bernier has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Daniel Bernier?
Find contact details for 700 million professionals.